Wealthcare Advisory Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$591K Buy
2,489
+111
+5% +$23.1K 0.01% 665
2026
Q1
$502K Sell
2,378
-22
-0.9% -$4.74K 0.01% 698
2025
Q4
$493K Buy
2,400
+195
+9% +$36.7K 0.01% 699
2025
Q3
$346K Buy
2,205
+18
+0.8% +$2.78K 0.01% 794
2025
Q2
$367K Sell
2,187
-65
-3% -$9.65K 0.01% 727
2025
Q1
$310K Sell
2,252
-282
-11% -$35.9K 0.01% 736
2024
Q4
$300K Sell
2,534
-89
-3% -$10.4K 0.01% 717
2024
Q3
$290K Sell
2,623
-480
-15% -$50.2K 0.01% 734
2024
Q2
$305K Buy
3,103
+314
+11% +$32K 0.01% 673
2024
Q1
$312K Buy
+2,789
New +$301K 0.01% 658
2021
Q2
Sell
-55
Closed -$3K 740
2021
Q1
$3K Buy
+55
New +$3.04K ﹤0.01% 1764
2020
Q2
Sell
-33
Closed -$2K 456
2020
Q1
$2K Buy
+33
New +$1.71K ﹤0.01% 1269

Other funds holding CAH

Wealthcare Advisory Partners's CAH Position: Q2 2026 in Review

Wealthcare Advisory Partners increased its Cardinal Health (CAH) stake by 4.7% in Q2 2026, buying an estimated $23.1K and bringing the position to 2,489 shares worth $591K. The position accounts for 0.01% of the portfolio, ranked #665.

Wealthcare Advisory Partners first reported a position in CAH in Q1 2020 and has held it in 12 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Wealthcare Advisory Partners held 2,489 shares of Cardinal Health worth $591K as of Q2 2026.
  • Wealthcare Advisory Partners bought 111 Cardinal Health shares in Q2 2026, an estimated $23.1K.
  • Cardinal Health made up 0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #665 holding.
  • Wealthcare Advisory Partners first reported a position in Cardinal Health in Q1 2020 and has held it in 12 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.